ADVANCE ONLINE PUBLICATION  |  Open Access

CORRIGENDA

Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment

Markus Hoffmann^1,2,* , Yeonhwa Jin^1,2 , Stefan Pöhlmann^1,2,*

¹Infection Biology Unit, German Primate Center, 37077 Göttingen, Germany
²Faculty of Biology and Psychology, Georg-August-University Göttingen, 37073 Göttingen, Germany
* Correspondence: Markus Hoffmann(mhoffmann@dpz.eu)Stefan Pöhlmann(spoehlmann@dpz.eu)

Correction to: Cell Research https://doi.org/10.1038/s41422-020-00459-5, published online 20 January 2021

https://doi.org/10.1038/s41422-022-00713-y

FULL TEXT | PDF

Browse 239